Status:
COMPLETED
Reduction of Topical Anesthetic Time for Subcutaneous Port Access Using Ultrasound
Lead Sponsor:
Connecticut Children's Medical Center
Conditions:
Pain
Eligibility:
All Genders
3-17 years
Phase:
PHASE4
Brief Summary
Children ages 3-17 who are undergoing port access receive both standard care, topical medicine for numbing (LMX4), and the study intervention which utilizes ultrasound to speed the onset of LMX4 from ...
Eligibility Criteria
Inclusion
- Children ages 3-17 with subcutaneous port
Exclusion
- Emergent need for port access
- Allergy to lidocaine sodium lauryl sulfate
Key Trial Info
Start Date :
October 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2006
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00126919
Start Date
October 1 2004
End Date
October 1 2006
Last Update
February 9 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Connecticut Children's Medical Center
Hartford, Connecticut, United States, 06040